GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lumiera Health Inc (TSXV:NHP.H) » Definitions » Revenue per Share

Lumiera Health (TSXV:NHP.H) Revenue per Share : C$0.00 (TTM As of Aug. 2023)


View and export this data going back to 2013. Start your Free Trial

What is Lumiera Health Revenue per Share?

Lumiera Health's revenue per share for the three months ended in Aug. 2023 was C$0.00. Lumiera Health's revenue per share for the trailing twelve months (TTM) ended in Aug. 2023 was C$0.00.

Warning Sign:

Lumiera Health Inc revenue per share has been in decline over the past 3 years.

During the past 12 months, the average Revenue Per Share Growth Rate of Lumiera Health was -50.00% per year. During the past 3 years, the average Revenue Per Share Growth Rate was -20.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate.

The historical rank and industry rank for Lumiera Health's Revenue per Share or its related term are showing as below:

TSXV:NHP.H' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -32.5   Med: -26.55   Max: -20.6
Current: -20.6

During the past 10 years, Lumiera Health's highest 3-Year average Revenue Per Share Growth Rate was -20.60% per year. The lowest was -32.50% per year. And the median was -26.55% per year.

TSXV:NHP.H's 3-Year Revenue Growth Rate is not ranked
in the Drug Manufacturers industry.
Industry Median: 6.4 vs TSXV:NHP.H: -20.60

Lumiera Health Revenue per Share Historical Data

The historical data trend for Lumiera Health's Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lumiera Health Revenue per Share Chart

Lumiera Health Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Nov18 Nov19 Nov20 Nov21 Nov22
Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.01 0.01 0.01 - -

Lumiera Health Quarterly Data
Sep18 Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23
Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Lumiera Health's Revenue per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Lumiera Health's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lumiera Health's PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Lumiera Health's PS Ratio distribution charts can be found below:

* The bar in red indicates where Lumiera Health's PS Ratio falls into.



Lumiera Health Revenue per Share Calculation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Lumiera Health's Revenue Per Share for the fiscal year that ended in Nov. 2022 is calculated as

Revenue Per Share (A: Nov. 2022 )=Revenue (A: Nov. 2022 )/Shares Outstanding (Diluted Average) (A: Nov. 2022 )
=0.631/169.965
=0.00

Lumiera Health's Revenue Per Share for the quarter that ended in Aug. 2023 is calculated as

Revenue Per Share (Q: Aug. 2023 )=Revenue (Q: Aug. 2023 )/Shares Outstanding (Diluted Average) (Q: Aug. 2023 )
=0.081/169.965
=0.00

Revenue per Share for the trailing twelve months (TTM) ended in Aug. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lumiera Health  (TSXV:NHP.H) Revenue per Share Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:

Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Lumiera Health Revenue per Share Related Terms

Thank you for viewing the detailed overview of Lumiera Health's Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Lumiera Health (TSXV:NHP.H) Business Description

Traded in Other Exchanges
N/A
Address
4500 Kimber, Suite 26, Saint-Hubert, QC, CAN, J3Y 8K5
Lumiera Health Inc is a natural health products company. The company is developing products focusing on the endocannabinoid system and providing treatments for chronic pain and inflammation.

Lumiera Health (TSXV:NHP.H) Headlines

No Headlines